China SXT Pharmaceuticals, Inc. Net Fee Amt
China SXT Pharmaceuticals, Inc. (SXTC) had Net Fee Amt of $52.40 thousand as of 2026-07-02, per its F-3 filed 2026-07-07.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-07
- 2026-07-02: Net Fee Amt $52.40K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-02 | $52.40K F-3 · filed 2026-07-07 |